Effects of alcohol on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules

Journal of Clinical Pharmacology

Volumn 52, Issue 5, 2012, Pages 747-756

  Johnson, Franklin K ^a   Ciric, Sabrina ^b   Boudriau, Sophie ^b   Kisicki, James ^b   Stauffer, Joseph ^a,c  

^a Alpharma Pharmaceuticals LLC   (United States)

^b MDS Inc   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alcohol; extended release; morphine; opioids; pharmacokinetics

Indexed keywords

ALCOHOL; MORPHINE SULFATE PLUS NALTREXONE;

ADULT; ARTICLE; CROSSOVER PROCEDURE; DRUG ALCOHOL INTERACTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG INTERACTION; DRUG RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SINGLE DRUG DOSE;

ADULT; ALCOHOL DRINKING; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CAPSULES; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; DRUG INTERACTIONS; ETHANOL; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; YOUNG ADULT;

EID: 84860284724     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011403740     Document Type: Article

References (14)

1. Substance Abuse and Mental Health Services Administration. Results From the 2007 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08-4343. Rockville, MD: Office of Applied Studies; 2008. http://www.oas.samhsa.gov/NSDUH/2k7NSDUH/ 2k7results.cfm. Accessed August 19, 2009.
2. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2006: National Estimates of Drug-Related Emergency Department Visits. Office of Applied Studies, DAWN Series D-30, DHHS Publication No. SMA 08-4339. Rockville, MD: Office of Applied Studies; 2008. http://dawninfo.samhsa. gov/files/ed2006/dawn2k6ed.htm. Accessed August 19, 2009.
3. Weathermon R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health. 1999 ; 23: 40-54
4. US Food and Drug Administration. Alert for Healthcare Professionals: Hydromorphone Hydrochloride Extended-Release Capsules (marketed as Palladone). July2005. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm129288.htm. Accessed August 20, 2009.
5. Bristol, TN: King Pharmaceuticals, Inc ; 2008:
6. Chadds Ford, PA: Endo Pharmaceuticals, Inc; ; 2008:
7. Fiske W, Benedek I, Ahdieh H. Bioavailability of oxymorphone extended-release tablets following consumption of alcohol or food [abstract 241]. J Pain. 2008 ; 9 (suppl 4). P36
8. Bristol, TN: King Pharmaceuticals, Inc; ; 2009:
9. Johnson F, Wagner G, Sun S, Stauffer J. Effect of concomitant ingestion of alcohol on the in vivo pharmacokinetics of KADIAN (morphine sulfate extended-release) capsules. J Pain. 2008 ; 9: 330-336
10. US Food and Drug Administration. In Vivo Drug Metabolism/Drug Interaction Studies-Study Design, Data Analysis, and Recommendations for Dosing and Labeling. Rockville, MD: Center for Drug Evaluation and Research; November1999. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM072119.pdf. Accessed August 20, 2009.
11. US Food and Drug Administration. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. Rockville, MD: Center for Drug Evaluation and Research; March2003. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070124.pdf. Accessed August 20, 2009.
12. Misra AL Narcotic Antagonists: Naltrexone Pharmacochemistry and Sustained-Release Preparations. Willette RE Barnett G, ed. Rockville, MD: US Department of Health and Human Services (DHHS) ; 1981: 132-146.
13. Johnson F, Jones JB, Stauffer J. Relative bioavailability of plasma naltrexone from crushed ALO-01 (an investigational, abuse-deterrent, extended-release, morphine sulfate formulation with sequestered naltrexone) to a naltrexone oral solution [abstract 236]. J Pain. 2008 ; 9 (suppl 4). P35
14. Johnson FK, Ciric S, Boudriau S, Swearingen D, Stauffer J. Effect of food and sprinkling of pellets on applesauce on the pharmacokinetics of ALO-01. Abstract presented at: American Association of Pharmaceutical Scientists (AAPS) ; Atlanta, GA ;..